Business Standard
Saturday, May 26, 2012
drived banner
drived banner
  Advanced Search
RSS
Content Guide
Follow us on  
||Companies & Industry||||||| 
 Section Home | News Now | Today's Paper | Q&A | People in the News | Industry News | Features | The Compass | Research & Analysis | Opinion | Corporate Results
Home > Companies & Industry Live Markets | Commodities
 

Atul Sobti quits Ranbaxy, Sawhney takes over
BS Reporter / New Delhi Aug 13, 2010, 03:29 IST

Ranbaxy Laboratories on Thursday said Atul Sobti had resigned as chief executive officer (CEO) and managing director.

The resignation would be effective August 19, said the company in a statement. It appointed Arun Sawhney, president of its global drug business, as managing director from August 20, but didn’t announce a replacement for the CEO position.

Ranbaxy
BSE | NSE
Price  
Ranbaxy Labs
This is the second top level change at Ranbaxy after Japanese drug company Daiichi Sankyo acquired a majority stake in it in 2008. Sobti, who joined Ranbaxy in October 2005, was promoted to head the company after former promoter Malvinder Mohan Singh quit the CMD’s (chairman and managing director’s) position in May 2009.

Sobti, whose three-year contract was to end in 2012, said the early exit was not a sudden decision, but was taken after several months of discussions with the Ranbaxy management.

“I have had healthy discussions (with Ranbaxy board) on multiple issues related to Ranbaxy’s future. After such a dialogue, when you believe there is no consensus of opinion, it is better to leave,” Sobti said. However, he refused to divulge the details of the disagreement.

“With the exit of Sobti, the entire old guard of Ranbaxy is out now. It may not have an impact on Ranbaxy performance, as Daiichi has enough management width,” Jagannadham Thunuguntla, equity head of merchant banking firm SMC Capitals said.

Ranbaxy Chairman Tsutomu Une said the company was “extremely grateful for the significant contribution of Sobti”.

Sobti took control of Ranbaxy when the company was facing setbacks in its US business. According to Sobti, Ranbaxy has crossed its troubled phase and is expecting an end to its US troubles in the next three-four months.

While Sobti said it was too early to finalise his next move, he was certain he would not be in the pharmaceutical business.

He had earlier led Hero Honda, another successful Indo-Japanese joint venture in India.

New Ipad Application :Business Standard's all new IPad App
Click here to download for free
Arrow Other Stories     
- Markets end flat
- Weekly: Markets end with marginal gains
- Sebi won't settle insider trading through consent
- Sail and Burn Standard sign JV to produce wagon components
- NHPC posts 28% rise in profit at Rs 2,772 cr for FY12
  Read Business news in 
- Journey on, We are by Your Side. Click here to know more
- 2 Lac Apartments, 1 Lac House / Plots. Click here
- Benefits Upto Rs. 2.36 Lakhs on the Fully Loaded TJet Petrol.
- The Best Seller is Also the No. 1 in Mileage. Click here
- Watch The Film Here. Click here to know more..
- Leader in Passenger Car & Automobile Tyres. Click here
- 1 billion in saving for Unilever without any tangles.
- A Brand New Server at a Price That Fits Your Budget. Click here
- Learn How One City is Running on FOOD SCRAPS.
- One Partnership Endless Possibilities. Click here to know more
- Helping doctors detect diseases earlier, saving costs & extending lives.
- 36 Lakhs can get you a pool of Luxuries. Click here
- Which is the best plan for your daughter
- Check out the TRUE COLOURS of your Stocks, Now for FREE!
- One of the leading business schools in the world.Know More
Sorry, comments to this story are closed
Latest Messages
Table for Two
  Now available at Special price
  Rs.280/- Only

  Buy Now
BS POLL
UPA 2 has completed three years. How do you rate its performance?  Read the story
  Good
  Average
  Bad
Submit
Most Popular
Read
E-Mailed
Commented
   
- Reddy rules out rollback of rise in petrol prices
- FIIs bet heavily in Indian market, but in Singapore
- IPL on turning track, broadcast revenue down by a third
- Ajit Singh meets striking pilots
- No country for easy skill development
 
 More  
Tax Shastra
  Now available at Special price
  Rs. 360/- Only

  Buy Now
 
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring BS Books
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World | General News
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Contact Us